IQSM
IQ Candriam U.S. Mid Cap Equity ETF
IQSM tracks a market cap-weighted index that provides exposure to US mid-cap stocks that meet environmental, social, and corporate governance criteria.
US
EQUITY
Rules-Based
MANAGEMENT STYLE
$ 422.3 M
ASSETS UNDER MGMT
16 bp
EXPENSES
Fund Basics
| Inception date | Oct 25, 2022 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | Quarterly |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | No |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
| GUARDANT HEALTH, INC. | 0.9 % |
| US FOODS HOLDING CORP. | 0.9 % |
| VIATRIS, INC. | 0.9 % |
| PTC INC. | 0.9 % |
| ROKU, INC. CLASS A | 0.8 % |
| BEST BUY CO INC | 0.7 % |
| IDEX CORP | 0.7 % |
| HF SINCLAIR CORPORATION | 0.7 % |
| ITT, INC. | 0.7 % |
| HOST HOTELS & RESORTS INC | 0.7 % |
Constituent Breakdown
| Number of holdings | 247 |
| Herfindahl-Hirschman Index | 47 |
| Wgt avg mkt cap (mns) | $11,908 |
| Large cap (>$10bn) | 65.3% |
| Mid cap ($2-10bn) | 31.1% |
| Small cap (<$2bn) | 0.2% |
| Developed mkts. | 96.4% |
| Emerging mkts. | 0.6% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 92.6 % |
 |
IRELAND | 1.2 % |
 |
BERMUDA | 0.9 % |
 |
CHINA | 0.6 % |
Historical Performance
Standardized Performance (as of 09/30/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | 11.0% | 13.4% | 8.1% | 13.0% | -- | -- | -- | 10.7% |
| Dividend Yield | 0.8% | 1.3% | 1.3% | 1.4% | -- | -- | -- | 1.3% |
| Total Returns | 11.9% | 14.6% | 9.4% | 14.3% | -- | -- | -- | 12.0% | Ann. Volatility | 15.0% | 14.8% | 17.8% | 17.3% | -- | -- | -- | 17.6% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 0.94 | 68% |
| MSCI EAFE | 0.71 | 58% |
| MSCI Emg Mkts | 0.39 | 45% |
Liquidity Measures
| Avg. volume (000) | 72 |
| ADV traded (mns) | $3 |
| Turnover | 0.7% |
| Avg. Bid/Ask (% of price) | 0.17% |
Technical Indicators
| 30d moving avg. (EMA) | $39.04 |
| Relative strength (RSI) | 52 |
| MACD/Signal | 0.07/-0.03 |
| Bollinger Bands (Upper/Lower) | $39.53/$38.22 |
| Short interest (% of AUM) | 0.1% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. IQSM |
Expenses vs. IQSM |
ALTAR Score™ vs. IQSM |
|---|---|---|---|---|
| BKMC | BNY Mellon US Mid Cap Core Equity ETF | 62.9% | -12 bp | +0.3% |
| BBMC | JPMorgan BetaBuilders U.S. Mid Cap Equity ETF | 46.6% | -9 bp | -0.5% |
| SCHM | Schwab U.S. Mid-Cap ETF | 45.4% | -13 bp | +0.4% |
| XJH | iShares ESG Screened S&P Mid-Cap ETF | 42.8% | -4 bp | +0.4% |
| MDY | SPDR S&P Midcap 400 ETF Trust | 42.2% | +7 bp | +0.6% |
| MIDE | Xtrackers S&P MidCap 400 ESG ETF | 41.6% | -1 bp | +1.1% |
| SPMD | State Street SPDR Portfolio S&P 400 Mid Cap ETF | 40.5% | -13 bp | +0.8% |
| IJH | iShares Core S&P Mid-Cap ETF | 40.0% | -11 bp | +0.8% |
| IVOO | Vanguard S&P Mid-Cap 400 ETF | 39.9% | -9 bp | +0.7% |
| QVMM | Invesco S&P MidCap 400 QVM Multi-factor ETF | 38.8% | -1 bp | +0.7% |
Risk and Returns: IQSM vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 11/6/2026
Peer Group Comparison
Sample data. Subscribe for access.
Historical Valuation Trends Sample data. Subscribe for access.
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
6.5%
ALTAR SCORE™
65th
PERCENTILE
OVERWEIGHT
ETFRC RATING
There are 1,388 funds in the US Equity category with an average
ALTAR Score™ of 5.7% and a standard deviation
of 2.1%. IQSM's ALTAR Score™ is approximately 0.4 standard
deviations above the category average. This places IQSM in the 65th percentile
among funds in the category.
Sell-Side Consensus
$47.72
PRICE TARGET
+23.9%
UPSIDE